Thermal vapour ablation to reduce segmental volume in patients with severe emphysema: STEP-UP 12 month results

Affiliations

• ¹ The National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton, London SW3 6NP, UK; Harefield NHS Foundation Trust, London, UK; Imperial College, London, UK. Electronic address: pallav.shah@imperial.ac.uk.
• ² Department of Pneumology and Critical Care Medicine Thoraxklinik, University of Heidelberg, Heidelberg, Germany; Translational Lung Research Center Heidelberg, Heidelberg, Germany; The German Lung Research Foundation (DZL), Heidelberg, Germany.
• ³ Department of Respiratory and Critical Care Medicine, Ludwig-Boltzmann-Institute for COPD and Respiratory Epidemiology, Otto-Wagner-Hospital, Vienna, Austria.
• ⁴ The National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton, London SW3 6NP, UK; Harefield NHS Foundation Trust, London, UK; Imperial College, London, UK.
• ⁵ Medical Clinic of Pneumology, Gemeinschaftskrankenhaus Havelhöhe, Berlin, Germany.
• ⁶ Advanced Lung Disease Program, Mater Misericordiae University Hospital, Dublin, Ireland.
• ⁷ Department of Respiratory Medicine, Allergology and Sleep Medicine, General Hospital Nuernberg, Nuremberg, Germany; Paracelsus Medical University, Nuremberg, Germany.
• ⁸ Pneumology, Charité Campus-Mitte, Berlin, Germany.
• ⁹ Lung Transplant Unit, Prince Charles Hospital, Chermside, Australia.
• ¹⁰ Asklepios-Fachkliniken Munich-Gauting, Comprehensive Pneumology Center Munich, Gauting, Germany.
• ¹¹ Western Australia Lung Research, Sir Charles Gairdner Hospital, Perth, Australia.
• ¹² Zentrum für Pneumologie, Hemer, Germany.
• ¹³ Department for Pulmonary Diseases, AK, Harburg, Hamburg, Germany.
• ¹⁴ Medical University of South Carolina, Charleston, USA.
• ¹⁵ Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital, Melbourne, Australia; Monash University, Melbourne, Australia.